current
pandem
presenc
rna
sampl
nucleic
acid
na
molecular
analysi
method
avail
diagnos
diseas
assess
patient
infect
recent
demand
laboratori
reagent
greatli
increas
particular
worldwid
shortag
rna
extract
kit
describ
fast
simpl
inexpens
method
detect
sar
rna
includ
pretreat
proteinas
k
heatingcool
cycl
amplif
method
bypass
rna
extract
step
lead
higher
amount
avail
viral
rna
compar
autom
extract
method
gener
profil
subsequ
amplif
phase
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
sinc
outbreak
newli
appear
sever
acut
respiratori
syndrom
caus
coronaviru
diseas
demonstr
viru
presenc
nasopharyng
swab
subsequ
molecular
analysi
viral
nucleic
acid
na
prefer
diagnost
method
sever
na
autom
analyt
molecular
system
avail
although
advantag
obtain
pure
product
highest
qualiti
expens
greatli
lengthen
analysi
procedur
importantli
recent
abil
manufactur
reagent
molecular
diagnost
meet
increas
demand
progress
diminish
particular
main
limit
repres
shortag
na
extract
kit
sinc
demonstr
viru
sampl
way
realli
indic
patient
infect
shortag
risk
greatli
impair
abil
limit
spread
pandem
tragic
consequ
addit
even
reagent
avail
na
isol
repres
signific
part
analyt
protocol
elimin
step
increas
product
laboratori
decreas
cost
test
solv
abovement
issu
develop
procedur
treatment
nasopharyng
swab
collect
patient
suspect
infect
elimin
need
rna
extract
step
autom
rna
extract
nasopharyng
swab
nasopharyng
swab
collect
tube
copan
diagnost
use
ie
plastic
screw
cap
tube
maintain
organ
viabil
hour
room
temperatur
less
fdaapprov
system
suitabl
collect
transport
longterm
rna
isol
nasopharyng
swab
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
dtt
revers
transcriptas
sampl
nucleasefre
water
mix
brought
total
volum
sampl
mix
droplet
gener
oil
probe
biorad
catalog
number
droplet
gener
autom
droplet
gener
droplet
gener
biorad
pcr
amplif
perform
thermal
cycler
thermofish
scientif
anneal
standard
thermal
cycl
condit
droplet
read
droplet
reader
biorad
reaction
less
droplet
repeat
data
analyz
use
softwar
biorad
statist
analys
perform
graphpad
prism
shapirowilk
test
perform
assess
normal
data
distribut
data
report
mean
sd
pearson
linear
regress
perform
assess
correl
measur
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
pair
student
test
perform
compar
two
popul
p
p
p
p
great
number
nucleic
acid
extract
kit
use
prepar
viral
sampl
analysi
earli
itali
face
exponenti
outbreak
infect
origin
china
sinc
declar
pandem
highli
impact
healthcar
system
around
world
respons
ten
thousand
death
molecular
test
current
best
avail
approach
correct
diagnosi
establish
infect
potenti
patient
rna
extract
nasopharyng
swab
patient
affect
becom
bottleneck
diagnost
procedur
due
enorm
quantiti
sampl
daili
process
shortag
extract
kit
avail
mani
instanc
shortag
induc
limit
test
patient
symptom
often
nonspecif
way
mani
asymptomat
paucisymptomat
individu
test
becom
major
vehicl
infect
spread
first
china
rest
world
overcom
issu
set
inhous
protocol
pretreat
swab
sampl
perform
rtqpcr
compar
result
amplif
automatedli
extract
viral
rna
swabderiv
materi
treat
describ
method
shown
figur
panel
sampl
display
amplif
profil
minim
differ
valid
data
employ
techniqu
higher
sensit
droplet
digit
pcr
ddpcr
use
sampl
autom
extract
method
found
viral
copi
ie
show
inhous
pretreat
protocol
reliabl
rapid
method
assess
infect
directli
nasopharyng
swab
fig
panel
b
furthermor
sinc
autom
diagnost
extract
system
use
studi
requir
swabderiv
materi
templat
method
need
materi
abl
detect
twice
much
viral
genom
sampl
moreov
assess
correl
inhous
rna
isol
method
autom
rna
extract
linear
regress
perform
use
rtqpcr
amplif
data
sampl
shapirowilk
normal
test
perform
shown
figur
pearson
r
two
group
ci
p
suggest
high
correl
methodolog
consid
perform
pretreat
protocol
gener
higher
amount
viral
rna
compar
autom
one
test
sensit
assess
viral
copi
two
amplif
method
rtqpcr
rtddpcr
perform
serial
dilut
sampl
use
figur
assess
amplif
curv
rtqpcr
shown
figur
panel
abl
evalu
viral
copi
even
dilut
high
effect
assess
mani
actual
viral
copi
protocol
abl
detect
use
approach
use
rtddpcr
shown
figur
panel
b
inhous
protocol
abl
detect
copi
directli
nasopharyng
swabderiv
materi
data
allow
us
optim
pretreat
protocol
publish
fomsgaard
rosenstiern
conclus
treatment
enabl
sar
rna
amplif
least
sensit
accur
perform
rna
extract
use
commerci
kit
time
rapid
spread
shortag
reagent
rna
extract
significantli
slow
test
process
effect
way
contrast
pandem
simpl
fast
protocol
overcom
limit
bypass
need
rna
extract
reagent
shorten
time
analysi
reduc
cost
serial
dilut
patient
sampl
isol
novel
custom
protocol
af
ntc
use
test
sensit
rtqpcr
rtddpcr
b
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
